1. Introduction {#s0005}
===============

Vitamin D has many roles in the regulation of the mineral homeostasis as well as other non-skeletal functions. Of these roles, increasing insulin secretion and insulin sensitivity ([@b0090]). Studies have shown that a low serum level of vitamin D increases the risk of developing diabetes ([@b0005], [@b0085], [@b0100]). Other studies have found that vitamin D deficiency is associated with complications of diabetes such as neuropathy and retinopathy ([@b0075]). However, little is known about the strength of the association between Vitamin D levels and glucose control.

Only a few studies have examined the association between vitamin D levels and diabetic control. A study conducted in Iran evaluated the effect of vitamin D on insulin resistance in patients with Type 2 diabetes. Researchers found that raising the level of vitamin D improved the fasting plasma glucose and reduced insulin resistance in these patients ([@b0095]). Another study that was conducted in Saudi Arabia found that vitamin D supplementation significantly improved their insulin resistance and lipid profile ([@b0010]). A couple of studies used HbA~1c~ as an outcome, which might had a better estimation of diabetes control over fasting blood glucose (FBG) ([@b0045], [@b0060], [@b0070]). However, no studies were found to determine the association between vitamin D and glycemic control in diabetic patients in the U.S.

Based on the Institute of Medicine (IOM), there are four categories of vitamin D status: (1) risk of deficiency: if the level of serum 25-hydroxyvitamin D (25OHD) is less than 12 ng/ml, (2) risk of inadequacy: if the level of 25OHD is between 12 to less than 20 ng/ml, (3) sufficiency: if the level of 25OHD is between 20 to 50 ng/ml, (4) and possibly harmful: if the level of 25OHD is more than 50 ng/ml ([@b0080]). In 2011, a report claimed that about 32% of United States population had a level of vitamin D of less than sufficiency ([@b0065]).

The purpose of this retrospective cross-sectional study was to examine the relationship between levels of vitamin D and diabetes control among patients with diabetes (both Type 1 and 2 but not gestational) drawn from National Health and Nutrition Examination Survey (NHANES) 2003--2006. We also explored the association between HbA~1c~ levels and serum vitamin D status (deficiency or non-deficiency) in patients with diabetes in the U.S.

Patients with diabetes are more susceptible to have serious health complications such as cerebrovascular disease, retinopathy, coronary heart disease, nephropathy and neuropathy. From this study we will be able to know the effect of vitamin D level on the HbA~1c~ that may help to reduce the complications of diabetes. Moreover, the study will describe the vitamin D status among the patients with diabetes.

2. Materials and methods {#s0010}
========================

2.1. Design {#s0015}
-----------

Secondary database analysis using data collected in NHANES that used a cross-sectional design.

2.2. Data source {#s0020}
----------------

NHANES is a program of studies designed to assess the health and nutritional status of adults and children in the United States. It is implemented by the US National Center for Health Statistics, part of the Centers for Disease Control and Prevention. NHANES uses a multistage stratified sampling design to collect data from the non-institutionalized civilian US population. The survey is unique in that it combines interviews, physical examinations, and laboratory tests.

The analysis sample consists of non-pregnant diabetic persons 18 years or older selected from the NHANES 2003--2006 cross-sections. We used the data from 2003 to 2006 because the measurement technique was changed after 2006 in the dataset, and the vitamin D level was not available at the time of analysis. A participant was excluded if HbA~1c~ or serum vitamin D level data was missing. The participants were defined as having diabetes if they answer yes to the question, "they have ever been told by a doctor or health professional that they have diabetes or sugar diabetes" in the NHANES questionnaire.

### 2.2.1. Dependent variable {#s0025}

#### 2.2.1.1. HbA1c and diabetes control {#s0030}

According to the American Diabetic Association (ADA), the goal for HbA~1c~ for non-pregnant adults is less than 7% \[53 mmol/L\]. Therefore, participants who had HbA~1c~ less than 7% \[53 mmol/L\] were considered to have glucose control ([@b0015]).

### 2.2.2. Independent variable {#s0035}

#### 2.2.2.1. Serum vitamin D deficiency {#s0040}

From the categories of vitamin D levels, we classified the participants into two groups. The first group consisted of participants with serum vitamin D ≥ 20 ng/ml (non-vitamin D deficiency). The second group consisted of participants with serum vitamin D \< 20 ng/ml (vitamin D deficiency).

### 2.2.3. Control variables {#s0045}

The analysis included the following additional covariates: age (young adults, aged 18--44, middle age adults, ages 45--64, and elderly, 65 years or older), race/ethnicity (non-Hispanic White, non-Hispanic Black, Hispanic, and other), gender, body mass index (BMI), having health insurance or not, type of diabetic medications used, and co-morbid conditions (i.e., hypertension, anemia, cholesterol, liver disease, and kidney disease). Diabetic patients were characterized into four groups based on Body Mass Index (i.e., underweight if the BMI was \<18.5, normal weight if the BMI was between 18.5 and 24.9, overweight if the BMI was between 25 and 29.9, and obese if the BMI was ≥30). In regard to the type of diabetic medications, the precipitants were also classified into one of four groups (i.e., not using medications, using insulin only, using oral medication only, or using both insulin and oral medications).

2.3. Statistical analysis {#s0050}
-------------------------

Statistical analysis was performed using STATA® 11.0 statistical package. Data were weighted to represent the U.S. non-pregnant diabetic adults aged ≥18 years. Descriptive analyses were conducted to characterize the participant and to examine demographic differences between patients by Vitamin D deficiency category. Student's *t* test was used to compare the difference in HbA~1c~ means between diabetic patients with and without a vitamin D deficiency. A multivariate logistic regression model was used to predict the relationship between glucose control (HbA~1c~ \<7% \[53 mmol/L\]) and vitamin D deficiency. Adjusted odds ratios, 95% confidence intervals were used to present the results, and the significance was set at P \< 0.05.

3. Results {#s0055}
==========

The study population included a total of 929 non-institutionalized, non-pregnant, diabetic adult persons that represent a total of 15,233,753 similar persons in the entire United States. Demographic characteristics and medication use and co-morbidity characteristics of the study sample are presented in [Table 1](#t0005){ref-type="table"}, [Table 2](#t0010){ref-type="table"}, respectively. The participants were mainly of middle to older age, overweight or obese, and roughly have equivalent distribution in gender. The majority used only oral medications for diabetes and had health insurance, and most of the participants reported having comorbidities including hypertension and hypercholesterolemia.Table 1Demographic characteristics of diabetic patients, 2003--2006, U.S.CharacteristicNumber (%)Gender Male465 (50.1) Female464 (49.9)  Age Young adults (18--44 year)104 (11.2) Middle age adults (45--64368 (39.6) Elderly (≥65 year)457 (49.2)  Race/ethnicity Hispanic264 (28.4) Non-Hispanic White382 (41.1) Non-Hispanic Black246 (26.5) Other37 (4.0)  Body mass index Under weight4 (0.4) Normal weight141 (15.2) Over weight285 (30.7) Obese499 (53.7)Table 2Medication use, and co-morbidity characteristics of diabetic patients, 2003--2006, U.S.CharacteristicNumber (%)Medication use[\*](#tblfn1){ref-type="table-fn"}(927 responses) Oral medication only549 (59.22) Oral medication and insulin110 (11.87) Insulin132 (14.24) No medication136 (14.67)  Having health insurance[\*](#tblfn1){ref-type="table-fn"}(928 Responses) Yes825 (88.90) No103 (11.10)  Having anemia[\*](#tblfn1){ref-type="table-fn"}(927 Responses) Yes58 (6.26) No869 (93.74)  Having hypertension[\*](#tblfn1){ref-type="table-fn"}(925 Responses) Yes621 (67.14) No304 (32.86)  Having hypercholesterolemia[\*](#tblfn1){ref-type="table-fn"}(813 Responses) Yes502 (61.75) No311 (38.25)Having liver disease[\*](#tblfn1){ref-type="table-fn"}(923 Responses) Yes62 (6.72) No861 (93.28)  Having kidney disease[\*](#tblfn1){ref-type="table-fn"}(923 Responses) Yes85 (9.2) No839 (90.8)[^1]

3.1. Vitamin D deficiency {#s0060}
-------------------------

In the U.S. in 2003--2006, we found that more than half (57%) of non-institutionalized, non-pregnant, adults with diabetes had a vitamin D deficiency. The Somewhat more females (279/464 \[60%\]) than males (251/465 \[54%\]) with diabetes were deficient in vitamin D. In regard to age, young adults with diabetes (18--44 years) had the highest rate of deficiency (72/104 \[69%\]), and the vitamin D deficiency in the middle age adults with diabetes (45--64 years) were (217/368 \[59%\]), while it was 52% (241/457) in elderly patients. Black patients with diabetes had an extremely high rate of vitamin D deficiency at (194/246\[79%\]). Hispanics with diabetes also had an above average rate of deficiency (170/264\[64%\]). Whites with diabetes were much less likely than the other groups to be deficient ([Fig. 1](#f0005){ref-type="fig"}). In terms of BMI, underweight patients with diabetes had a high rate of deficiency (3/4 \[75%\]). The vitamin D deficiency in normal weight patients with diabetes were (61/141 \[43.26%\], while the vitamin D deficiency in overweight patients with diabetes were (145/285 \[51%\]), and obese patients with diabetes were (321/499 \[64.33\]).Fig. 1Vitamin D status in diabetic patients in U.S., 2003--2006, by race/ethnicity.

3.2. Association of HbA~1c~ and vitamin D deficiency {#s0065}
----------------------------------------------------

The result of student's *t* test that was done for 929 patients showed that the means of the HbA~1c~ were significantly different between diabetic patients with no vitamin D deficiency and those with a vitamin D deficiency (7.06% \[54 mmol/L\], 7.56% \[59 mmol/L\], respectively, P \< 0.0001. Results from multiple regression modeling after adjustment for age, race/ethnicity, gender, BMI, having health insurance or not, type of diabetic medications used, and co-morbid conditions (hypertension, anemia, cholesterol, liver disease, kidney disease) are presented in [Table 3](#t0015){ref-type="table"}. The analysis sample consists of 802 respondents without missing values for all the variables. The result shows that a small but insignificant, increase in odds (11%) of having uncontrolled diabetes exists in patients with a vitamin D deficiency after adjustment for control variables.Table 3Results of the adjusted logistic regression model, for the effect of vitamin D deficiency in diabetic control (n = 802).Independent variableAdjusted odds ratio (95%)P valueVitamin D Non-deficient--Reference Deficient0.891 \[CI: 0.58--1.38\]0.605  Medication Oral medication only--Reference Oral medication and Insulin0.31 \[CI: 0.17--0.57\]0.000[\*](#tblfn2){ref-type="table-fn"} Insulin0.30 \[CI: 0.17--0.55\]0.000[\*](#tblfn2){ref-type="table-fn"} No medication4.05 \[CI: 2.15--7.66\]0.000[\*](#tblfn2){ref-type="table-fn"}  Gender Female--Reference Male0.76 \[CI: 0.51--1.14\]0.184  Race/ethnicity Non-Hispanic White--Reference Hispanic0.43 \[CI: 0.24--0.78\]0.006[\*](#tblfn2){ref-type="table-fn"} Non-Hispanic Black0.47 \[CI: 0.29--0.74\]0.001[\*](#tblfn2){ref-type="table-fn"} Other0.86 \[CI: 0.36--2.04\]0.735  Age Middle age adult (45--64 year)--Reference Young adult (18--44 year)0.95 \[CI: 0.47--1.89\]0.884 Elderly (≥65 year)1.79 \[CI: 1.16--2.79\]0.009[\*](#tblfn2){ref-type="table-fn"}  BMI Normal weight--Reference Under weight7.57 \[CI: 0.35--162.31\]0.196 Over weight1.51 \[CI: 0.80--2.85\]0.201 Obese1.89 \[CI: 1.02--3.52\]0.043  Having health insurance No--Reference Yes1.6 \[CI: 0.79--3.26\]0.192  Having anemia No--Reference Yes1.62 \[CI: 0.77--3.40\]0.203  Having hypertension No--Reference Yes1.26 \[CI: 0.79--2.02\]0.335  Having hypercholesterolemia No--Reference Yes0.87 \[CI: 0.58--1.32\]0.512  Having liver disease No--Reference Yes0.91 \[CI: 0.41--2.05\]0.826  Having kidney disease No--Reference Yes0.65 \[CI: 0.34--1.27\]0.209[^2]

The model showed that the patients with diabetes who do not use medication were more likely to have controlled diabetes than those who were using oral medication (adjusted OR: 4.05 \[95% CI 2.15--7.66\]), while the patients who were using insulin or insulin and oral medication were less likely to have controlled diabetes compared to the patients who were using oral medication only (adjusted OR: 0.30 \[95% CI 0.17--0.55\]), (adjusted OR: 0.30 \[95% CI 0.17--0.57\] respectively).

In regard to race/ethnicity, the results showed that Hispanic and non-Hispanic Black patients with diabetes were less likely to have controlled diabetes than non-Hispanic White patients with diabetes (adjusted OR: 0.43 \[95% CI 0.24--0.78\]), (adjusted OR: 0.47 \[95% CI 0.29--0.74\]) respectively. The results also showed that obese patients with diabetes were more likely to have controlled diabetes than those with normal weight (adjusted OR: 1.89 \[95% CI 1.02--3.52\]). Lastly, the models showed that elderly patients with diabetes were more likely to have controlled diabetes than middle age adult patients with diabetes (adjusted OR: 1.79 \[95% CI 1.16--2.79\]).

Furthermore, we conducted sub-analysis in Hispanic, non-Hispanic White, and non-Hispanic Black groups to assess the relationship between vitamin D and glycemic control. The regression model showed that vitamin D deficiency was not a significant factor when stratified by subgroup. (Adjusted OR for Hispanic, non-Hispanic White, and non Hispanic Black: 0.64 \[95% CI 0.25--1.64\], 0.95 \[95% CI 0.54--1.67\], and 0.97 \[95% CI 0.36--2.06\], respectively).

4. Discussion {#s0070}
=============

To our knowledge, this the first study in the United States that has evaluated the vitamin D status in patients with diabetes and studied the association between HbA~1c~ levels and vitamin D status among patients with diabetes using national representative sample (NHANES). The findings of our study showed that there is a significant unadjusted difference in HbA~1c~ between the diabetic patients with no vitamin D deficiency group and diabetic patients with a vitamin D deficiency group. However, after we added the other variables to the model and ran the logistic regression, the findings indicated that there was only a small association that lacked statistical significance between vitamin D deficiency and glucose control in patients with diabetes.

The other findings of our study that displayed in [Table 3](#t0015){ref-type="table"} indicated that patients with diabetes who use combined insulin and oral medications or insulin only were less likely to be controlled compared to patients who used oral medication only. Also, the finding shows that patients who did not use any medication for diabetes were more likely to be controlled than patients who used oral medication. This might be explained by the natural history of type-2 diabetes, which is characterized by continuous declining in β-cells function and worsening of insulin resistance as the disease progress. Patients with no medication use might be in the first stage of the disease progression with healthier β-cells than patients on diabetic medications and they could be maintaining a healthy diet, exercising, and other lifestyle modifications. Likewise, β-cell function and insulin resistance of patients on combined insulin and oral medications or insulin only might be worse than patients on oral medication only and resulting in uncontrolled glycemic levels. Moreover, many clinical trials showed an increasing loss of glycemic control over time as type-2 diabetes progresses, which manifested clinically by deterioration in A1C levels and thus require more aggressive treatment. Further evaluation and explanations to the study findings were limited due to the cross-sectional design of the survey ([@b0050], [@b0105], [@b0110]).

Also, our findings show that Hispanic and non-Hispanic Black patients were less likely to be controlled compared to non-Hispanic White patients. These were similar to results of previous work that compared the difference in HbA~1c~ between African American and non-Hispanic White ([@b0055]). These results could be attributed to the level of the access to quality care or the different lifestyles of the race/ethnicity groups ([@b0065]).

One of our findings in this study indicated that vitamin D deficiency is more common in patients with diabetes. Patients with diabetes are almost twice as likely to have vitamin D deficiency (57%) as compared to general population (32%) ([@b0065]). This could have consequences beyond glycemic control because low vitamin D levels are associated with many other health risks including bone disease, cancer, cognitive impairment, and death from cardiovascular disease ([@b0020], [@b0025], [@b0030], [@b0040], [@b0115], [@b0120]).

The results showed that non Hispanic Black patients with diabetes had the highest rate of vitamin D deficiency. This finding could be due to the fact that dark skin produces less vitamin D ([@b0035]). So, we did a subgroup analysis to determine if there is a difference between each race/ethnicity in regards to glycemic control and vitamin D deficiency. However, no association was found when the data was stratified by race/ethnicity.

The strength of our study is that we used a nationally representative sample of the U.S. population. NHANES oversamples minority groups, which help to give better estimates of population trends. One limitation of our study is that the analysis is based on a cross-sectional survey, which means that measurements of vitamin D levels and HbA~1c~ were taken only once and are subject to measurement error. Also, we did not separate diabetes into Type 1/Type 2 because there is no question in the NHANES questionnaire allows separating between the two types accurately. Separation between the types of diabetes in a future study may give different results.

5. Conclusion {#s0075}
=============

In conclusion, vitamin D deficiency is more common in patients with diabetes. Therefore, monitoring of serum vitamin D level in diabetics is advised. Although we found that correcting the level of vitamin D is not likely to improve glycemic control, other studies suggested that vitamin D supplementation may help to reduce the development of other health risks such as bone diseases, cognitive impairment, and cardiovascular diseases.
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[^1]: Some patients did not answer all the questions in the survey.

[^2]: Statistical significant.
